| Product Code: ETC9942240 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) DNA & RNA Banking Services Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) DNA & RNA Banking Services Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) DNA & RNA Banking Services Market - Industry Life Cycle |
3.4 United Kingdom (UK) DNA & RNA Banking Services Market - Porter's Five Forces |
3.5 United Kingdom (UK) DNA & RNA Banking Services Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United Kingdom (UK) DNA & RNA Banking Services Market Revenues & Volume Share, By Specimen Type, 2021 & 2031F |
3.7 United Kingdom (UK) DNA & RNA Banking Services Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 United Kingdom (UK) DNA & RNA Banking Services Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 United Kingdom (UK) DNA & RNA Banking Services Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and precision healthcare |
4.2.2 Advances in genetic research and technology leading to a growing need for DNA RNA banking |
4.2.3 Rising awareness about the importance of genetic testing and disease prevention |
4.3 Market Restraints |
4.3.1 High costs associated with DNA RNA banking services |
4.3.2 Lack of standardized regulations and guidelines in the UK for DNA RNA banking |
4.3.3 Limited access to genetic counseling and education for the general population |
5 United Kingdom (UK) DNA & RNA Banking Services Market Trends |
6 United Kingdom (UK) DNA & RNA Banking Services Market, By Types |
6.1 United Kingdom (UK) DNA & RNA Banking Services Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) DNA & RNA Banking Services Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United Kingdom (UK) DNA & RNA Banking Services Market Revenues & Volume, By Transportation Service, 2021- 2031F |
6.1.4 United Kingdom (UK) DNA & RNA Banking Services Market Revenues & Volume, By Processing Service, 2021- 2031F |
6.1.5 United Kingdom (UK) DNA & RNA Banking Services Market Revenues & Volume, By Storage Service, 2021- 2031F |
6.1.6 United Kingdom (UK) DNA & RNA Banking Services Market Revenues & Volume, By Quality Control Service, 2021- 2031F |
6.1.7 United Kingdom (UK) DNA & RNA Banking Services Market Revenues & Volume, By Data Storage, 2021- 2031F |
6.1.8 United Kingdom (UK) DNA & RNA Banking Services Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United Kingdom (UK) DNA & RNA Banking Services Market, By Specimen Type |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) DNA & RNA Banking Services Market Revenues & Volume, By Blood, 2021- 2031F |
6.2.3 United Kingdom (UK) DNA & RNA Banking Services Market Revenues & Volume, By Buccal Swabs & Hair Follicles, 2021- 2031F |
6.2.4 United Kingdom (UK) DNA & RNA Banking Services Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United Kingdom (UK) DNA & RNA Banking Services Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) DNA & RNA Banking Services Market Revenues & Volume, By Therapeutics, 2021- 2031F |
6.3.3 United Kingdom (UK) DNA & RNA Banking Services Market Revenues & Volume, By Drug Discovery & Clinical Research, 2021- 2031F |
6.3.4 United Kingdom (UK) DNA & RNA Banking Services Market Revenues & Volume, By Clinical Diagnostics, 2021- 2031F |
6.3.5 United Kingdom (UK) DNA & RNA Banking Services Market Revenues & Volume, By Other Applications, 2021- 2031F |
6.4 United Kingdom (UK) DNA & RNA Banking Services Market, By End-use |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) DNA & RNA Banking Services Market Revenues & Volume, By Academic Research, 2021- 2031F |
6.4.3 United Kingdom (UK) DNA & RNA Banking Services Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.4.4 United Kingdom (UK) DNA & RNA Banking Services Market Revenues & Volume, By Hospitals & Diagnostic Centers, 2021- 2031F |
6.4.5 United Kingdom (UK) DNA & RNA Banking Services Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) DNA & RNA Banking Services Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) DNA & RNA Banking Services Market Export to Major Countries |
7.2 United Kingdom (UK) DNA & RNA Banking Services Market Imports from Major Countries |
8 United Kingdom (UK) DNA & RNA Banking Services Market Key Performance Indicators |
8.1 Adoption rate of DNA RNA banking services among healthcare providers |
8.2 Number of partnerships between DNA RNA banking service providers and research institutions |
8.3 Percentage of the population with access to genetic testing and counseling |
8.4 Rate of technological advancements in DNA RNA storage and analysis techniques |
9 United Kingdom (UK) DNA & RNA Banking Services Market - Opportunity Assessment |
9.1 United Kingdom (UK) DNA & RNA Banking Services Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United Kingdom (UK) DNA & RNA Banking Services Market Opportunity Assessment, By Specimen Type, 2021 & 2031F |
9.3 United Kingdom (UK) DNA & RNA Banking Services Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 United Kingdom (UK) DNA & RNA Banking Services Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 United Kingdom (UK) DNA & RNA Banking Services Market - Competitive Landscape |
10.1 United Kingdom (UK) DNA & RNA Banking Services Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) DNA & RNA Banking Services Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here